SOC 2 & 21 CFR Part 11 Announcement
SOC 2 & 21 CFR Part 11 Announcement Voxeleron is now SOC 2 Type 1 certified and in compliance with FDA’s 21 CFR Part 11. Taking excellent care of customer data is our highest priority, and we are invested in…
Eyes on the Prize: Spotlight on AI-Driven Innovations
Eyes on the Prize: Spotlight on AI-Driven Innovations The advancement of artificial intelligence (AI) is driving innovation in ophthalmic research. While there are still challenges to be addressed, there is marked progress in applying AI to improve many aspects of…
Eyes on the Prize: Challenges Using AI in Ophthalmology
Eyes on the Prize: Challenges Using AI in Ophthalmology The use of artificial Intelligence (AI) in global healthcare is expected to expand at a compound annual growth rate of 38.4% from 2022 to 2030. While AI is driving compelling innovation…
Eyes on the Prize: The Case for AI in Ophthalmic Clinical Research
Eyes on the Prize: The Case for AI in Ophthalmic Clinical Research The pace of innovation in ophthalmic research continues to advance, yet costly issues with clinical trial recruitment, management and analysis persist. Instead of settling for the status quo,…
Who Sets the “Standard”? Enabling Interoperability in Ophthalmic Image Analysis
Who Sets the “Standard”? Enabling Interoperability in Ophthalmic Image Analysis Why are standards needed in ophthalmology? The evolution of data science and artificial intelligence has made standards a pressing issue. Ophthalmology has the most imaging technologies and imaging device manufacturers…
